You searched for "outcomes"
Cancer associated retinopathy
Abdul Muhyemin Tarin reviews the presentation, pathophysiology and management of this paraneoplastic syndrome. Case presentation A 60-year-old hypermetropic female patient presented with several months’ history of painless blurred vision. Visual acuity (VA) was 6/24 and 6/9-1 in right and left...Therapy for limbal stem cell deficiency: cell fate after limbal stem cell transplants
1 October 2014
| Aws Al-Hity, Sanjay Mantry, Ken Lai, K Ramaesh
|
EYE - Cornea
“The beauty of scientific research lies in that the search for answers often yields yet more questions.” A large body of evidence points to the corneoscleral limbal location as the repository of putative epithelial stem cells [1]. Thoft proposed the...
Emerging therapies for geographic atrophy: complement inhibitors show potential to slow progression and preserve RPE and photoreceptor integrity
5 June 2023
| Rod McNeil
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) characterised by progressive, irreversible loss of the retinal pigment epithelium (RPE) and photoreceptors and is estimated to account for approximately 10% of AMD-related blindness [1-4]. The Age-Related Eye...
See sweet to C-suite: Imran Rahman
See also - See sweet to C-suite: Peter Holland In this three-part conversation series, Co-editor David Lockington speaks with highly influential individuals about their journey to the top, with advice for the next generation of leaders. Part Two: David speaks...Minister for equalities backs Sight Scotland’s push to break down accessibility barriers in Scottish venues
Equalities Minister Kaukab Stewart recently met with Sight Scotland’s Policy Group to discuss the importance of improving access and inclusion in Scotland’s venues. She stressed that everyone should have the freedom to enjoy life and visit places of their choice,...The College of Optometrists publishes Interim Position on AI in Eye Care
The College of Optometrists has today published its Interim Position on the Use of Artificial Intelligence (AI) in Eye Care setting out the UK optical sector’s collective stance on the safe and responsible implementation of AI in eyecare. The College...Love will tear us apart again
4 February 2025
| Peter Cackett
|
EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Sophie: Bye. Love you! Mark: I love you, too. (It’s okay, everyone says it. I say I love Häagen-Dazs and my broadband provider, and I like Sophie more than them. In most respects.) Yes, Valentine’s Day is fast approaching again...
100% Optical and Optrafair organisers join forces
27 July 2020
From now on there will be one major annual exhibition, 100% Optical at London’s ExCeL exhibition centre, which has full industry support from the FMO and other major optical bodies.
Celebrating volunteer ophthalmic nurses on #InternationalNursesDay
12 May 2022
Eye News and eye care charity Orbis celebrate volunteer ophthalmic nurses who worked on the frontlines during the pandemic.
Orbis eye health programme integrated into school curriculum in Nepal
Leading eyecare charity Orbis and Nepal’s National Society of Comprehensive Eye Care (NNJS) have worked together since 2019 to implement a programme called REACH (Refractive Error Among Children) in Eastern Nepal.More action on sepsis needed as NHS Ombudsman still seeing same failings a decade on
The UK’s Health Ombudsman has warned that sepsis is still taking too many lives due to the same hospital failings we were seeing over ten years ago.Age and gender impacts effectiveness of new gene therapy treatments for eye diseases, new study finds
14 February 2025
|
research, genetics, gene therapy, pathology, education, Adeno-Associated Virus, inflammation
Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular Therapy, reveal how age and gender affects inflammation caused by gene...